Advances in diabetes for the millennium: Diabetes in women CME

MedGenMed Medscape General Medicine

Volumn 6, Issue 3 SUPPL., 2004, Pages

  Jovanovic, Lois ^a  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIOXIDANT; ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHROMIUM; CHROMIUM PICOLINATE; CONJUGATED ESTROGEN; ESTRADIOL; GESTODENE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; METFORMIN; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PIPERAZINE ESTRONE SULFATE; PROGESTERONE; TROGLITAZONE;

AMENORRHEA; ARTICLE; AUTOMATION; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DELAYED PUBERTY; DEVELOPMENTAL DISORDER; DRUG DELIVERY SYSTEM; EMOTIONAL DISORDER; FEMALE; FEMALE INFERTILITY; FETUS MALFORMATION; GENDER; GLUCOSE BLOOD LEVEL; GROWTH DISORDER; HORMONE SUBSTITUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INTELLECTUAL IMPAIRMENT; MEDICAL EDUCATION; MENOPAUSAL SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE OSTEOPOROSIS; PRECOCIOUS PUBERTY; PREGNANCY DIABETES MELLITUS; PREGNANCY RATE; TERATOGENICITY; ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; PHYSIOLOGY; PREGNANCY; REVIEW; SEX DIFFERENCE;

DIABETIC NEUROPATHIES; HUMANS; ADOLESCENT; ADULT; CHILD; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; INSULIN; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; PREGNANCY; PREGNANCY IN DIABETICS; SEX FACTORS;

EID: 27444439745     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bullen BA, Skrinar GS, Beitins IZ, et al. Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med. 1985;312:1349-1353.
2. Ding JH, Sheckter CB, Drinkwater BL, Soules MR, Bremner WJ. High serum cortisol levels in exercise-associated amenorrhea. Ann Intern Med. 1988;108:530-534L.
3. Loucks AB, Mortola JF, Girton L, Yen SS. Alterations in the hypothalamic-pituitary-ovarian and the hypothalamic-pituitary-adrenal axes in athletic women. J Clin Endocrinol Metab. 1989;68:402-411.
4. Marcus R, Cann C, Madvig P, et al. Menstrual function and bone mass in elite women distance runners. Endocrine and metabolic features. Ann Intern Med. 1985;102:158-163.
5. Loucks AB, Laughlin GA, Mortola JF, et al. Hypothalamic-pituitary-thyroidal function in eumenorrheic and amenorrheic athletes. J Clin Endocrinol Metab. 1992;75:514-518.
6. Tanner JM, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985;107:317-329.
7. Willi SM, Planton J, Egede L, Schwarz S. Reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes using insulin glargine and neutral protamine Hagedorn insulin. J Pediatr. 2003;143:737-740.
8. Chase HP, Dixon B, Pearson J, et al. The journey to metabolic control in diabetes: many more miles to go. J Pediatr. 2003;143:704-706.
9. Silverstein JH, Rosenbloom AL. Results of continuous glucose monitoring by GlucoWatch Biographer in a cohort of diabetic children and adolescents under real-life conditions. Pediatr Diabetes. 2003;4:57-58.
10. Bozzetti V, Viscardi M, Bonfanti R, et al. The variable but inevitable loss of beta cells in overt type 1 diabetes. Pediatr Diabetes. 2003;4:1-3.
11. Rosenbloom AL. The impact of diabetes on health-related quality of life in children and adolescents. Pediatr Diabetes. 2003;4:132-136.
12. Cameron FJ. Insulin glargine improves hemoglobin A1c in children and adolescents with poorly controlled type 1 diabetes. Pediatr Diabetes. 2003;4:64-69.
13. Dunger DB. Will the use of insulin analogs improve glycemic control during adolescence? Pediatr Diabetes. 2003;4:61-63.
14. Marcus MD, Wing RR, Guare J, Blair EH, Jawad A. Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients. Diabetes Care. 1992;15:253-255.
15. Snow-Harter C, Marcus R. Exercise, bone mineral density, and osteoporosis. Exerc Sport Sci Rev. 1991;19:351-388.
16. Pocock N, Eisman J, Gwinn T, et al. Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass. J Bone Miner Res. 1989;4:441-448.
17. Rodgers JB, Monier-Faugere MC, Malluche H. Animal models for the study of bone loss after cessation of ovarian function. Bone. 1993;14:369-377.
18. Bunt JC, Going SB, Lohman TG, et al. Variation in bone mineral content and estimated body fat in young adult females. Med Sci Sports Exerc. 1990;22:564-569.
19. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res. 1993;8:567-573.
20. van der Mooren MJ, Wouters MG, Blom HJ, et al. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest. 1994;24:733-736.
21. Daneman D, Drash AL, Lobes LA, et al. Progressive retinopathy with improved control in diabetic dwarfism (Mauriac's syndrome). Diabetes Care. 1981;4:360-365.
22. Tamborlane WV, Puklin JE, Bergman M, et al. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care. 1982;5 (suppl1):58-64.
23. Baker JP, Haber GB, Gray RR, Handy S. Emphysematous cholecystitis complicating endoscopic retrograde cholangiography. Gastrointest Endosc. 1982;28:184-186.
24. Jovanovic L, Druzin M, Peterson CM. Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects. Am J Med. 1981;71:921-927.
25. Jovanovic L. Controversies in the diagnosis and treatment of gestational diabetes. Cleve Clin J Med. 2000;67:481-482,485-486,488. Review.
26. Pedersen J. Diabetes mellitus and pregnancy: present status of the hyperglycaemia - hyperinsulinism theory and the weight of the newborn baby. Postgrad Med J. 1971;(suppl):66-67.
27. Mills JL. Malformations in infants of diabetic mothers. Teratology. 1982;25:385-394.
28. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988;319:1617-1623.
29. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA. 1991;265:731-736.
30. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998;17:548-555.
31. Jovanovic L, Gondos B. Type 2 diabetes: the epidemic of the new millennium. Ann Clin Lab Sci. 1999;29:33-42.
32. Jovanovic L, Ilic S, Pettitt DJ, et al. Metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care. 1999;22:1422-1427.
33. Siman CM, Gittenberger-De Groot AC, Wisse B, Eriksson UJ. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology. 2000;61:355-367.
34. Yang X, Borg LA, Siman CM, Eriksson UJ. Maternal antioxidant treatments prevent diabetes-induced alterations of mitochondrial morphology in rat embryos. Anat Rec. 1998;251:303-315.
35. Wentzel P, Eriksson UJ. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes. 1998;47:677-684.
36. Eriksson UJ, Wentzel P, Minhas HS, Thornalley PJ. Teratogenicity of 3-deoxyglucosone and diabetic embryopathy. Diabetes. 1998;47:1960-1966.
37. Wentzel P, Eriksson UJ. Antioxidants diminish developmental damage induced by high glucose and cyclooxygenase inhibitors in rat embryos in vitro. Diabetes. 1998;47:677-684.
38. Siman CM, Eriksson UJ. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia. 1997;40:1416-1424.
39. Morin-Papunen LC, Vauhkonen I, Koivunen RM, et al. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study. J Clin Endocrinol Metab. 2000;85:3161-3168.
40. Taylor R, Marsden PJ. Insulin sensitivity and fertility. Hum Fertil (Camb). 2000;3:65-69.
41. Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab. 2000;85:2767-2774.
42. Bunt JC, Going SB, Lohman TG, et al. Variation in bone mineral content and estimated body fat in young adult females. Med Sci Sports Exerc. 1990;22:564-569.
43. Felson DT, Zhang Y, Hannan MT, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med. 1993;329:1141-1146.